Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Li

Showing results (151-160 of 206) with videos related to

Pageof 21
Sort By:
Nature Reviews. Urology|March 28, 2023
Circulating and urinary tumour DNA in urothelial carcinoma - upper tract, lower tract and metastatic diseaseKyle M Rose, Heather L Huelster, Joshua J Meeks, et al.
Nature Reviews. Urology|May 22, 2023
Author Correction: Circulating and urinary tumour DNA in urothelial carcinoma - upper tract, lower tract and metastatic diseaseKyle M Rose, Heather L Huelster, Joshua J Meeks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2023
A Phase II Study of Durvalumab for Bacillus Calmette-Guerin (BCG) Unresponsive Urothelial Carcinoma In Situ of the BladderRoger Li, Wade J Sexton, Jasreman Dhillon, et al.
Urologic Oncology|August 3, 2025
Oncologic and survival outcomes in patients undergoing radical nephroureterectomy with preoperative or iatrogenic dialysis dependenceMatthew S Lee, Patrick J Hensley, Daniel Igel, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Reduced Dose Intravesical Bacillus Calmette-Guérin: Why It Might Not MatterAshish M Kamat, Niyati Lobo, Seth P Lerner, et al.
European Urology Oncology|January 6, 2024
Comparative Effectiveness of Neoadjuvant Pembrolizumab Versus Cisplatin-based Chemotherapy or Upfront Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder CancerRoger Li, Luigi Nocera, Kyle M Rose, et al.
JAMA Network Open|December 27, 2023
Genomic Profiles and Clinical Outcomes of Penile Squamous Cell Carcinoma With Elevated Tumor Mutational BurdenAndrea Necchi, Philippe E Spiess, Tiago Costa de Padua, et al.
Urologic Oncology|March 23, 2023
Impact of surgical margin and extent of lymphadenectomy on oncologic outcomes in plasmacytoid urothelial carcinomaFacundo Davaro, Elizabeth Davaro, Kyle Rose, et al.
Nature Reviews. Urology|September 10, 2025
Low-grade non-muscle-invasive bladder cancer: molecular landscape, treatment strategies and emerging therapiesLexiaochuan Wen, Hiroko Miyagi, Philippe E Spiess, et al.
The Oncologist|January 20, 2026
Fanconi Anemia Complementation Group C Gene (FANCC) Association with Hereditary and Sporadic Renal TumorsDevashish Desai, Rebecca A Sager, Michael Basin, et al.
Pageof 21

Showing results (151-160 of 206) with videos related to

Sort By:
Pageof 21
Nature Reviews. Urology|March 28, 2023
Circulating and urinary tumour DNA in urothelial carcinoma - upper tract, lower tract and metastatic diseaseKyle M Rose, Heather L Huelster, Joshua J Meeks, et al.
Nature Reviews. Urology|May 22, 2023
Author Correction: Circulating and urinary tumour DNA in urothelial carcinoma - upper tract, lower tract and metastatic diseaseKyle M Rose, Heather L Huelster, Joshua J Meeks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2023
A Phase II Study of Durvalumab for Bacillus Calmette-Guerin (BCG) Unresponsive Urothelial Carcinoma In Situ of the BladderRoger Li, Wade J Sexton, Jasreman Dhillon, et al.
Urologic Oncology|August 3, 2025
Oncologic and survival outcomes in patients undergoing radical nephroureterectomy with preoperative or iatrogenic dialysis dependenceMatthew S Lee, Patrick J Hensley, Daniel Igel, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Reduced Dose Intravesical Bacillus Calmette-Guérin: Why It Might Not MatterAshish M Kamat, Niyati Lobo, Seth P Lerner, et al.
European Urology Oncology|January 6, 2024
Comparative Effectiveness of Neoadjuvant Pembrolizumab Versus Cisplatin-based Chemotherapy or Upfront Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder CancerRoger Li, Luigi Nocera, Kyle M Rose, et al.
JAMA Network Open|December 27, 2023
Genomic Profiles and Clinical Outcomes of Penile Squamous Cell Carcinoma With Elevated Tumor Mutational BurdenAndrea Necchi, Philippe E Spiess, Tiago Costa de Padua, et al.
Urologic Oncology|March 23, 2023
Impact of surgical margin and extent of lymphadenectomy on oncologic outcomes in plasmacytoid urothelial carcinomaFacundo Davaro, Elizabeth Davaro, Kyle Rose, et al.
Nature Reviews. Urology|September 10, 2025
Low-grade non-muscle-invasive bladder cancer: molecular landscape, treatment strategies and emerging therapiesLexiaochuan Wen, Hiroko Miyagi, Philippe E Spiess, et al.
The Oncologist|January 20, 2026
Fanconi Anemia Complementation Group C Gene (FANCC) Association with Hereditary and Sporadic Renal TumorsDevashish Desai, Rebecca A Sager, Michael Basin, et al.
Pageof 21